Find Research Outputs

Search in all content

Filters for Research Output

Search concepts
Selected Filters

Publication Year

  • 2019
  • 2018
  • 2017
  • 2016

Author

  • Marilyn K Glassberg Csete
2019

Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Glassberg Csete, M. K., Nathan, S. D., Lin, C. Y., Morgenthien, E. A., Stauffer, J. L., Chou, W. & Noble, P. W., Jan 1 2019, (Accepted/In press) In : Advances in Therapy.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

Correction to: Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (Advances in Therapy, (2019), 36, 10, (2910-2926), 10.1007/s12325-019-01052-y)

Glassberg, M. K., Nathan, S. D., Lin, C. Y., Morgenthien, E. A., Stauffer, J. L., Chou, W. & Noble, P. W., Oct 1 2019, In : Advances in Therapy. 36, 10, p. 2927-2929 3 p.

Research output: Contribution to journalComment/debate

Open Access

Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis

Costabel, U., Albera, C., Glassberg Csete, M. K., Lancaster, L. H., Wuyts, W. A., Petzinger, U., Gilberg, F., Kirchgaessler, K. U. & Noble, P. W., Mar 12 2019, In : Respiratory Research. 20, 1, 55.

Research output: Contribution to journalArticle

Open Access
8 Scopus citations

Effect of pirfenidone on breathlessness in patients with idiopathic pulmonary fibrosis

Glassberg, M. K., Wijsenbeek, M. S., Gilberg, F., Petzinger, U., Kirchgaessler, K. U. & Albera, C., Sep 1 2019, In : The European respiratory journal. 54, 3

Research output: Contribution to journalLetter

Open Access
1 Scopus citations

Efficacy of Pirfenidone in the Context of Multiple Disease Progression Events in Patients With Idiopathic Pulmonary Fibrosis

Nathan, S. D., Costabel, U., Glaspole, I., Glassberg Csete, M. K., Lancaster, L. H., Lederer, D. J., Pereira, C. A., Trzaskoma, B., Morgenthien, E. A., Limb, S. L. & Wells, A. U., Jan 1 2019, In : CHEST.

Research output: Contribution to journalArticle

Open Access
4 Scopus citations

Intravenous stem cell dose and changes in quantitative lung fibrosis and DLCO in the AETHER trial: A pilot study

Fishman, J. E., Kim, G. H. J., Kyeong, N. Y., Goldin, J. G. & Glassberg, M. K., Jan 1 2019, In : European review for medical and pharmacological sciences. 23, 17, p. 7568-7572 5 p.

Research output: Contribution to journalArticle

1 Scopus citations

MicroRNA let-7 downregulates ligand-independent estrogen receptor–mediated male-predominant pulmonary fibrosis

Elliot, S., Periera-Simon, S., Xia, X., Catanuto, P., Rubio, G., Shahzeidi, S., El Salem, F., Shapiro, J., Briegel, K., Korach, K. S. & Glassberg, M. K., Nov 15 2019, In : American journal of respiratory and critical care medicine. 200, 10, p. 1246-1257 12 p.

Research output: Contribution to journalArticle

6 Scopus citations

Multipotent mesenchymal stromal cells and lung disease: Not ready for prime time

Purdon, S. & Glassberg Csete, M. K., Jan 1 2019, In : Annals of the American Thoracic Society. 16, 6, p. 669-671 3 p.

Research output: Contribution to journalEditorial

Multipotent Mesenchymal Stromal Cells for Pulmonary Fibrosis?

Purdon, S., Patete, C. L. & Glassberg Csete, M. K., May 1 2019, In : American Journal of the Medical Sciences. 357, 5, p. 390-393 4 p.

Research output: Contribution to journalReview article

2 Scopus citations
2 Scopus citations

Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry

Todd, J. L., Neely, M. L., Overton, R., Durham, K., Gulati, M., Huang, H., Roman, J., Newby, L. K., Flaherty, K. R., Vinisko, R., Liu, Y., Roy, J., Schmid, R., Strobel, B., Hesslinger, C., Leonard, T. B., Noth, I., Belperio, J. A., Palmer, S. M., Asi, W. & 43 others, Baker, A., Beegle, S., Belperio, J. A., Condos, R., Cordova, F., Culver, D. A., De Andrade, J. A. M., Dilling, D., Flaherty, K. R., Glassberg, M., Gulati, M., Guntupalli, K., Gupta, N., Case, A. H., Hotchkin, D., Huie, T., Kaner, R., Kim, H., Kreider, M., Lancaster, L., Lasky, J., Lederer, D., Lee, D., Liesching, T., Lipchik, R., Lobo, J., Mageto, Y., Menon, P., Morrison, L., Namen, A., Oldham, J., Raj, R., Ramaswamy, M., Russell, T., Sachs, P., Safdar, Z., Sigal, B., Silhan, L., Strek, M., Suliman, S., Tabak, J., Walia, R. & Whelan, T. P., Oct 22 2019, In : Respiratory research. 20, 1, 227.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: Insights from the IPF-PRO Registry

Snyder, L., Neely, M. L., Hellkamp, A. S., O'Brien, E., De Andrade, J., Conoscenti, C. S., Leonard, T., Bender, S., Gulati, M., Culver, D. A., Kaner, R. J., Palmer, S., Kim, H. J., Asi, W., Baker, A., Beegle, S., Belperio, J. A., Condos, R., Cordova, F., De Andrade, J. A. M. & 35 others, Dilling, D., Flaherty, K., Glassberg, M., Guntupalli, K., Gupta, N., Case, A. H., Hotchkin, D., Huie, T., Kreider, M., Lancaster, L., Lasky, J., Lederer, D., Lee, D., Liesching, T., Lipchik, R., Lobo, J., Mageto, Y., Menon, P., Morrison, L., Namen, A., Oldham, J., Raj, R., Ramaswamy, M., Russell, T., Sachs, P., Safdar, Z., Sigal, B., Silhan, L., Strek, M., Suliman, S., Tabak, J., Walia, R., Whelan, T. P., Fleming, J. & Morris, W., May 30 2019, In : Respiratory research. 20, 1, 105.

Research output: Contribution to journalArticle

Open Access
8 Scopus citations

Research in Pulmonary Fibrosis Across Species: Unleashing Discovery Through Comparative Biology

for the Comparative Biology of Pulmonary Fibrosis Group, May 2019, In : American Journal of the Medical Sciences. 357, 5, p. 399-404 6 p.

Research output: Contribution to journalArticle

2 Scopus citations

Stem cell therapies for lung regeneration

Patete, C. L. & Glassberg, M. K., Jan 1 2019, Encyclopedia of Tissue Engineering and Regenerative Medicine. Elsevier, Vol. 1-3. p. 115-126 12 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Systemic Sclerosis Associated Interstitial Lung Disease: New Directions in Disease Management

Mirsaeidi, M., Barletta, P. & Glassberg, M. K., Oct 31 2019, In : Frontiers in Medicine. 6, 248.

Research output: Contribution to journalReview article

Open Access

Trends in idiopathic pulmonary fibrosis-related mortality in the United States: 2000-2017

Dove, E. P., Olson, A. L. & Glassberg, M. K., Oct 1 2019, In : American journal of respiratory and critical care medicine. 200, 7, p. 929-931 3 p.

Research output: Contribution to journalLetter

3 Scopus citations
2018

Dose modification and dose intensity during treatment with pirfenidone: Analysis of pooled data from three multinational phase III trials

Nathan, S. D., Lancaster, L. H., Albera, C., Glassberg, M. K., Swigris, J. J., Gilberg, F., Kirchgaessler, K. U., Limb, S. L., Petzinger, U. & Noble, P. W., Aug 1 2018, In : BMJ Open Respiratory Research. 5, 1, e000323.

Research output: Contribution to journalArticle

9 Scopus citations

Estrogen receptor subtype expression and regulation is altered in papillary thyroid cancer after menopause

Rubio, G. A., Catanuto, P., Glassberg Csete, M. K., Lew, J. & Elliot, S., Jan 1 2018, In : Surgery (United States). 163, 1, p. 143-149 7 p.

Research output: Contribution to journalArticle

8 Scopus citations

High Stakes: Direct to Consumer Marketing of Unproven Stem Cell Treatments for Lung Disease

Glassberg Csete, M. K., Csete, I. S. & Toonkel, R. L., Jun 1 2018, In : Chest. 153, 6, p. 1294-1295 2 p.

Research output: Contribution to journalEditorial

3 Scopus citations

Mesenchymal stem cells for the treatment of idiopathic pulmonary fibrosis

Tzouvelekis, A., Toonkel, R., Karampitsakos, T., Medapalli, K., Ninou, I., Aidinis, V., Bouros, D. & Glassberg Csete, M. K., May 1 2018, In : Frontiers in Medicine. 5, MAY, 142.

Research output: Contribution to journalReview article

12 Scopus citations

Mesenchymal stromal cells prevent bleomycin-induced lung and skin fibrosis in aged mice and restore wound healing

Rubio, G. A., Elliot, S., Wikramanayake, T., Xia, X., Pereira-Simon, S., Thaller, S., Glinos, G. D., Jozic, I., Hirt, P., Pastar, I., Tomic-Canic, M. & Glassberg Csete, M. K., Jan 1 2018, (Accepted/In press) In : Journal of Cellular Physiology.

Research output: Contribution to journalArticle

3 Scopus citations

Optical coherence tomography for assessment of epithelialization in a human ex vivo wound model

Glinos, G. D., Verne, S. H., Aldahan, A. S., Liang, L., Nouri, K., Elliot, S., Glassberg, M., Cabrera Debuc, D., Koru-Sengul, T., Tomic-Canic, M. & Pastar, I., Jan 1 2018, (Accepted/In press) In : Wound Repair and Regeneration.

Research output: Contribution to journalArticle

3 Scopus citations

Response

Glassberg Csete, M. K., Khan, A. & Hare, J., Jan 1 2018, In : Chest. 153, 1, p. e9-e12

Research output: Contribution to journalLetter

2017

Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial

Glassberg Csete, M. K., Minkiewicz, J., Toonkel, R. L., Simonet, E. S., Rubio, G. A., DiFede, D., Shafazand, S., Khan, A., Pujol, M. V., LaRussa, V. F., Lancaster, L. H., Rosen, G. D., Fishman, J., Mageto, Y. N., Mendizabal, A. & Hare, J., May 1 2017, In : Chest. 151, 5, p. 971-981 11 p.

Research output: Contribution to journalArticle

64 Scopus citations

Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis

Nathan, S. D., Albera, C., Bradford, W. Z., Costabel, U., Glaspole, I., Glassberg Csete, M. K., Kardatzke, D. R., Daigl, M., Kirchgaessler, K. U., Lancaster, L. H., Lederer, D. J., Pereira, C. A., Swigris, J. J., Valeyre, D. & Noble, P. W., Jan 1 2017, In : The Lancet Respiratory Medicine. 5, 1, p. 33-41 9 p.

Research output: Contribution to journalArticle

102 Scopus citations

Exploring animal models that resemble idiopathic pulmonary fibrosis

Tashiro, J., Rubio, G. A., Limper, A. H., Williams, K., Elliot, S., Ninou, I., Aidinis, V., Tzouvelekis, A. & Glassberg Csete, M. K., Jan 1 2017, In : Frontiers in Medicine. 4, JUL, 118.

Research output: Contribution to journalReview article

Open Access
38 Scopus citations

Lung Diseases of the Elderly: Cellular Mechanisms

Ascher, K., Elliot, S., Rubio, G. A. & Glassberg Csete, M. K., Nov 1 2017, In : Clinics in Geriatric Medicine. 33, 4, p. 473-490 18 p.

Research output: Contribution to journalReview article

7 Scopus citations

Rheumatoid Arthritis-Associated Interstitial Lung Disease: Current Concepts

Brito, Y., Glassberg Csete, M. K. & Ascherman, D., Dec 1 2017, In : Current Rheumatology Reports. 19, 12, 79.

Research output: Contribution to journalReview article

8 Scopus citations
2016

Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: Analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis

Nathan, S. D., Albera, C., Bradford, W. Z., Costabel, U., Du Bois, R. M., Fagan, E. A., Fishman, R. S., Glaspole, I., Glassberg, M. K., Glasscock, K. F., King, T. E., Lancaster, L., Lederer, D. J., Lin, Z., Pereira, C. A., Swigris, J. J., Valeyre, D., Noble, P. W. & Wells, A. U., May 2016, In : Thorax. 71, 5, p. 429-435 7 p.

Research output: Contribution to journalArticle

87 Scopus citations

Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function

Albera, C., Costabel, U., Fagan, E. A., Glassberg, M. K., Gorina, E., Lancaster, L., Lederer, D. J., Nathan, S. D., Spirig, D. & Swigris, J. J., Sep 1 2016, In : European Respiratory Journal. 48, 3, p. 843-851 9 p.

Research output: Contribution to journalArticle

67 Scopus citations

Estrogen deficiency promotes cigarette smoke–induced changes in the extracellular matrix in the lungs of aging female mice

Glassberg Csete, M. K., Catanuto, P., Shahzeidi, S., Aliniazee, M., Lilo, S., Rubio, G. A. & Elliot, S., Dec 1 2016, In : Translational Research. 178, p. 107-117 11 p.

Research output: Contribution to journalArticle

5 Scopus citations

Pirfenidone for idiopathic pulmonary fibrosis: Analysis of pooled data from three multinational phase 3 trials

Noble, P. W., Albera, C., Bradford, W. Z., Costabel, U., Bois, R. M. D., Fagan, E. A., Fishman, R. S., Glaspole, I., Glassberg Csete, M. K., Lancaster, L., Lederer, D. J., Leff, J. A., Nathan, S. D., Pereira, C. A., Swigris, J. J., Valeyre, D. & King, T. E., Jan 1 2016, In : European Respiratory Journal. 47, 1, p. 243-253 11 p.

Research output: Contribution to journalArticle

156 Scopus citations

Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: Integrated analysis of cumulative data from 5 clinical trials

Lancaster, L., Albera, C., Bradford, W. Z., Costabel, U., Du Bois, R. M., Fagan, E. A., Fishman, R. S., Glaspole, I., Glassberg, M. K., King, T. E., Lederer, D. J., Lin, Z., Nathan, S. D., Pereira, C. A., Swigris, J. J., Valeyre, D. & Noble, P. W., Jan 1 2016, In : BMJ Open Respiratory Research. 3, 1, e000105.

Research output: Contribution to journalArticle

62 Scopus citations

What should be chronic: The animal, the model, or both?

Rubio, G. A., Elliot, S. & Glassberg Csete, M. K., 2016, In : Stem cells translational medicine. 5, 5, p. 703 1 p.

Research output: Contribution to journalArticle

2 Scopus citations